Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Business Wire

Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Thomas (Tom) Pike will join Labcorp as president and chief executive officer of its ...
Business Wire

Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development ...
Nasdaq

Predictive Oncology Inc. Develops Exclusive 3D Organoid Models for Labcorp to Enhance Drug Discovery and Safety Evaluation

Predictive Oncology Inc. has announced the successful development of 3D organoid models specifically for Labcorp, which include unique human and rat liver toxicity models. These models are designed to ...
Reuters

Labcorp misses profit estimates as drug development unit struggles

April 25 (Reuters) - Laboratory Corp of America Holdings (LH.N), opens new tab missed estimates for quarterly profit on Tuesday, as its drug development unit struggled against curbs on animal imports, ...
Nasdaq

Forge Biologics and Labcorp Announce Strategic AAV Gene Therapy Development and Manufacturing Collaboration

Innovative collaboration advances the development of novel gene therapies for patients by providing coordinated services across Forge’s leading AAV manufacturing capabilities and Labcorp’s scientific ...
PharmiWeb

Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs

Portfolio expansion solidifies company's commitment to advancing cancer research and patient care BURLINGTON, N.C., April 8, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and ...
Nature

Labcorp Drug Development, United Kingdom (UK)

The positions in the table below reflect the Labcorp Drug Development's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...
Medindia

Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...
Nature

Labcorp Drug Development

Article ‘Count’ and ‘Share’ for Labcorp Drug Development based on listed parameters only. The articles listed below published by authors from Labcorp Drug Development, organized by journal and article ...
GEN

LabCorp to Market On-Q-ity’s CTC Platform for Cancer Drug Discovery and Development

Firms claim microfluidics-based system will provide early indicator of drug response. LabCorp negotiated rights to market cancer diagnostics firm On-Q-ity’s circulating tumor cell (CTC) platform to ...